Volume 3.33 | Aug 21

Hematopoiesis News 3.33 August 21, 2012
Hematopoiesis News
     In this issue: Publications | Reviews | Industry News | Policy News | Events | Jobs
Cell Therapy News on Facebook  Hematopoiesis News on Twitter
H2.0-Like Homeobox Regulates Early Hematopoiesis and Promotes Acute Myeloid Leukemia
Scientists identified H2.0-like homeobox as a key regulator in immature hematopoietic and leukemia cells, and as a prognostic marker and therapeutic target in acute myeloid leukemia. [Cancer Cell]
Abstract | Press Release

[Free Webinar] A Guide To Successful Flow Cytometry Analysis of ALDHbr Cells - Watch Now.
PUBLICATIONS (Ranked by impact factor of the journal)


Tissue-Specific Mitotic Bookmarking by Hematopoietic Transcription Factor GATA1
Scientists investigated whether transcription factor GATA1 plays a role in transmitting hematopoietic gene expression programs through mitosis when transcription is transiently silenced. [Cell] Abstract

Genetic Alterations Activating Kinase and Cytokine Receptor Signaling in High-Risk Acute Lymphoblastic Leukemia
Scientists performed transcriptome and whole genome sequencing on 15 cases of Ph-like acute lymphoblastic leukemia and identified rearrangements involving ABL1, JAK2, PDGFRB, CRLF2, and EPOR, activating mutations of IL7R and FLT3, and deletion of SH2B3. Results showed that several of these alterations induce transformation that is attenuated with tyrosine kinase inhibitors, suggesting the treatment outcome of these patients may be improved with targeted therapy. [Cancer Cell] Abstract | Press Release

B Cells from Patients with Chronic GvHD Are Activated and Primed for Survival via BAFF Mediated Pathways
Since BAFF increases murine B cell metabolism, survival, and maintains autoreactive B cell clones, the authors performed ex vivo analyses of peripheral B cells from 51 patients who either had or did not have active chronic GvHD and were greater than one year from the time of allogeneic hematopoietic stem cell transplantation. [Blood] Abstract | Press Release

Activated Gs Signaling in Osteoblastic Cells Alters the Hematopoietic Stem Cell Niche in Mice
Investigators used a transgenic mouse model with the ColI(2.3) promoter driving a ligand-independent, constitutively active 5HT4 serotonin receptor to address how the massive increase in trabecular bone formation resulting from increased Gs-signaling in osteoblastic lineage cells impacts on hematopoietic stem cell function and blood production. [Blood] Abstract

Efficient Generation, Purification, and Expansion of CD34+ Hematopoietic Progenitor Cells from Nonhuman Primate Induced Pluripotent Stem Cells
Researchers developed a chemically defined, scalable and reproducible specification protocol with bone morphogenetic protein 4, prostaglandin E2, and StemRegenin1 for hematopoietic differentiation of Macaca nemestrina induced pluripotent stem cells. [Blood] Abstract

A Novel Molecular Mechanism Involved in Multiple Myeloma Development Revealed by Targeting MafB to Hematopoietic Progenitors
To explore early cellular changes that might take place in the development of plasma cell neoplasias, researchers engineered transgenic mice to express MafB in hematopoietic stem/progenitor cells. They suggest that, mechanistically, the hematopoietic progenitor population can be the target for transformation in MafB-associated plasma cell neoplasias. [EMBO J] Full Article

Immature Hematopoietic Stem Cells Undergo Maturation in the Fetal Liver
Hematopoietic stem cells (HSCs) are first found in the dorsal aorta after 10.5 days post coitus (dpc) and in the fetal liver at 11 dpc. However, lympho-myeloid hematopoietic progenitors are detected in the dorsal aorta from 9 dpc, raising the issue of their role in establishing adult hematopoiesis. Researchers showed that these progenitors are endowed with long-term reconstitution capacity, but only engraft natural killer-deficient Rag2γc−/− mice. [Development] Abstract

Mapping Differentiation Pathways from Hematopoietic Stem Cells Using Flk2/Flt3 Lineage Tracing
Researchers previously employed a lineage tracing approach to define hematopoietic differentiation pathways in relation to expression of the tyrosine kinase receptor Flk2. Here, they performed additional experiments to test alternative options of lineage specification, and discuss implications of these data for defining stem cell identity and lineage potential among hematopoietic populations. [Cell Cycle] Abstract

Deacetylase Inhibitors Modulate Proliferation and Self-Renewal Properties of Leukemic Stem and Progenitor Cells
Scientists investigated the effects of deacetylase inhibitors on leukemic stem and progenitor cells using murine transduction-transplantation models of hematopoietic cells harboring the leukemia-associated fusion proteins PLZF/RARα or a truncated acute myeloid leukemia 1/ETO protein. [Cell Cycle] Abstract


Phase II Study of Subcutaneous Omacetaxine Mepesuccinate after TKI Failure in Patients with Chronic-Phase CML with T315I Mutation
This phase II trial assessed the efficacy of omacetaxine in chronic myeloid leukemia (CML) patients with T315I and tyrosine kinase inhibitor (TKI) failure. [Blood] Abstract

Allogeneic Stem Cell Transplantation for Relapsed or Refractory Lymphoma after Conditioning with BEAM/Fludarabine/TBI
Allogeneic stem cell transplantation after BEAM/fludarabine/total body irradiation (TBI) provided excellent tumor control with complete and durable remissions in patients with poor-prognosis lymphoma and chronic lymphocytic leukemia. [Biol Blood Marrow Transplant] Abstract

[Free Webinar] ALDH+ Cancer Precursor Cells in Drug Response Prediction - Watch Now.

Based on your feedback, we’ve added a Reviews section to Hematopoiesis News
JAK/STAT Signaling in Hematological Malignancies
Researchers discussed the nature and respective contribution of mutations dysregulating the Janus kinase (JAK)/signal transducer and activator of transcription (STAT) pathway in hematological malignancies and presented examples in which such mutations drive the disease, contribute to the phenotype, or provide a survival and proliferative advantage. [Oncogene] Abstract
Omeros Has Now Unlocked Over Half of the Class A Orphan GPCRs
Omeros Corporation announced that it has identified compounds that functionally interact with each of five additional orphan G protein-coupled receptors (GPCRs), GPR22, GPR45, GPR63, GPR162 and GPR171. Omeros has now unlocked 42 Class A orphan GPCRs, representing over half of these targets. [Omeros Corporation] Press Release

ARIAD Begins Phase I/II Trial of Ponatinib in Japan
ARIAD Pharmaceuticals, Inc. announced the initiation of a multi-center Phase I/II clinical trial in Japan of ponatinib, the Company’s investigational BCR-ABL inhibitor. The trial is being conducted in Japanese patients with chronic myeloid leukemia who have failed treatment with dasatinib or nilotinib or with Philadelphia-chromosome positive acute lymphoblastic leukemia who have failed prior tyrosine kinase inhibitors. [ARIAD Pharmaceuticals, Inc.] Press Release

Funding for NIH in Jeopardy; Congress Plans Six Month Continuing Resolution
FY 2013 funding for the NIH is still very much in jeopardy. While the Senate Appropriations Committee passed its version of a FY 2013 L-HHS bill in June, which included $100 million more for the NIH, that is clearly unobtainable. The House L-HHS Appropriations Subcommittee passed its version of the bill in July flat-lining NIH funding and cutting several other Obama Administration priorities. [American Society of Hematology, United States] Press Release

Gillibrand Announces Bill to Spur the Growth of New Science and Technology Jobs in Capital Region
U.S. Senator Kirsten Gillibrand announced legislation to spur the growth of new science and technology jobs in the Capital Region and across New York. The America Innovates Act would help scientists and researchers secure valuable resources and training to turn new discoveries into marketable products, new high-tech companies, and jobs. [U.S. Senate, United States] Press Release

National Institutes of Health (United States)

Food and Drug Administration (United States)
Center for Biologics Evaluation and Research (United States)
European Medicines Agency (European Union)

Medicines and Healthcare Products Regulatory Agency (United Kingdom)

Therapeutic Goods Administration (Australia)


NEW 18th Annual Congress of the European Hematology Association (EHA)
June 13-16, 2013
Stockholm, Sweden

Visit our events page to see a complete list of events in the hematopoietic community.


Quality Control Operations Coordinator (STEMCELL Technologies, Inc.)

Research Technologist – Media Development (STEMCELL Technologies, Inc.)

Research Technologist – Research and Development (STEMCELL Technologies, Inc.)

Scientific Communications and Publishing Coordinator (STEMCELL Technologies, Inc.)

Scientist – Mesenchymal Cell Research (STEMCELL Technologies, Inc.)

Postdoctoral Position – Stem Cell Biology and Developmental Hematopoiesis (Mount Sinai School of Medicine)

Postdoctoral Position – Stem Cells (Children’s Hospital of Chicago Research Center)

Research Assistant – Hematopoietic Stem Cell Function (Geisel School of Medicine at Dartmouth)

Recruit Top Talent: Reach more than 55,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.

Have we missed an important article or publication in Hematopoiesis News? Click here to submit!

Comments or Suggestions? Email [email protected] with your feedback.

Learn more about Hematopoiesis Cell News: Archives | Events | Contact Us